Ridgeline, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics across Europe, US and RoW. In recent years, Ridgeline has assembled an international team of highly experienced drug discovery and industry professionals and built and operated multiple new successful companies; these companies have raised significant funds through Series B, IPO, Pharma Partnerships and an exit through a trade sale.
Company Details
- Employees
- 56
- Founded
- 2017
- Address
- Aeschenvorstadt 36, Basel,bs 4051,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Representative jobs.
- HQ
- Basel, BS
Ridgeline Discovery Questions
Ridgeline Discovery's website is http://www.ridgelinediscovery.com/
Ridgeline Discovery's LinkedIn profile is https://ch.linkedin.com/company/ridgeline-therapeutics
Ridgeline Discovery has
56 employees.
View email and phone details for 56
employees at Ridgeline Discovery.
Ridgeline Discovery's industry is
Biotechnology Research
Ridgeline Discovery's top competitors are
Red Ridge Bio,
Granite Bio,
Monte Rosa Therapeutics,
Versant Ventures,
Bright Peak Therapeutics,
Zenith Therapeutics,
Alentis Therapeutics,
Black Diamond Therapeutics,
Sixpeaks Bio,
Cimeio Therapeutics.
Ridgeline Discovery's categories are Biotechnology Research
Ridgeline Discovery's founding year is 2017
